We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Fingerprint Assay Accurately Identifies Users of Heroin and Cocaine

By LabMedica International staff writers
Posted on 02 Apr 2018
A test protocol based on liquid chromatography-mass spectrometry (LC-MS) analysis accurately detects levels of illegal drugs in a single fingerprint from drug users while eliminating those who had only passive contact with a drug user.

In an earlier study, investigators at the University of Surrey (United Kingdom) described a test that used a fingerprint to detect cocaine use. More...
Now, in a recent study, the group has improved on the earlier test by developing a new fingerprint protocol that detects both cocaine and heroin.

For this study, 100 fingerprint samples were collected from the hands of 50 nondrug users before and after handwashing to establish separate environmental cutoff values and testing protocols for cocaine, benzoylecgonine, heroin, and 6-monoacetylmorphine. The cutoff was challenged by testing the fingerprints of drug-free volunteers after shaking hands with drug users. Fingerprints from patients who testified to taking cocaine (n = 32) and heroin (n = 24) were also collected and analyzed. Analysis was carried out using the LC-MS gold standard drug testing method.

Results revealed that this protocol identified 100% of heroin users even after handwashing and gave a false positive for only one non-drug user who shook hands with a drug user. The investigators also used LC-MS to test for cocaine and its metabolite benzoylecgonine, which identified 85% of cocaine users after handwashing and produced no false positives for the non-drug users who came in contact with drug users. For both heroin and cocaine the fingerprint test correctly identified more drug users than saliva testing.

“The possibility of drug testing from a fingerprint has become the subject of many recent research articles, due to the ease and noninvasive nature of sample collection, as well as the fact that the donor’s identity is embedded within the ridge detail of the fingerprint itself,” said senior author Dr. Melanie Bailey, lecturer in chemistry at the University of Surrey. “This provides … the possibility of rapidly and noninvasively carrying out drug testing in a way that is difficult to falsify. This is, we believe, the first study to explore the significance of testing for drugs from a fingerprint, and therefore, the first effort dedicated to establishing an environmental cutoff.”

The study was published in the March 22, 2018, online edition of the journal Clinical Chemistry.

Related Links:
University of Surrey


Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.